The Swiss pharmaceutical firm's U.S. generic pill business could attract as much as $1.6 billion, Reuters reported.
With a boost from the NFL and its own IPO, Quanterix hopes to engage biopharma companies to use its platform to speed safety and efficacy results for neurology, oncology and inflammation pipelines.
We see a notable shift away from traditional large-cap pharmaceutical stocks to more specialized niches.
Nascar champion Danica Patrick talks about not being a gear head, her business ventures and how migraines have affected her life.
European and U.S. stocks are expected to drift lower Thursday as the dollar continues to bear the brunt of global uncertainty on trade and tax policy.